“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, ...
The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.